Participants will learn about the prevalence, incidence, and economic impact of venous thromboembolism and atrial fibrillation on patients, as well as the associated treatments and clinical data relating to efficacy, safety, and cost-efficacy.
Charles E. Mahan, PharmD, RPh, PhC
Advertisement
Articles by Charles E. Mahan, PharmD, RPh, PhC
Advertisement
Latest Updated Articles
- The Impact of Direct Oral Anticoagulants in the Managed Care Environment
December 17th 2015
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
5 Notable FDA Approvals From the First Half of 2026
3
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
4
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
5